Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll The acetylcholinesterase inhibitors for treatment of cognitive and behavioral symptoms in dementia with Lewy bodies Simard M; van Reekum RJ Neuropsychiatry Clin Neurosci 2004[Fal]; 16 (4): 409-25Dementia with Lewy bodies (DLB) is a common cause of dementia with effects on cognition, mood, behavior, and function. Changes in the acetylcholine system have been reported in brains of patients with DLB, which provides a rationale for trials of acetylcholinesterase inhibitors in DLB. This review includes all English-language publications found via Medline and related to the efficacy and/or safety of these compounds in DLB. Preliminary data suggest that these compounds may be efficacious in DLB and that future randomized clinical trials are strongly needed. Methodological limitations of the existing data include small sample sizes, and the paucity of standardized psychometric measures.|Aged[MESH]|Basal Ganglia Diseases/drug therapy[MESH]|Behavior/*drug effects[MESH]|Cholinesterase Inhibitors/adverse effects/*therapeutic use[MESH]|Clinical Trials as Topic[MESH]|Cognition Disorders/*drug therapy/*etiology[MESH]|Cognition/drug effects[MESH]|Donepezil[MESH]|Humans[MESH]|Indans/adverse effects/therapeutic use[MESH]|Lewy Body Disease/*drug therapy/*psychology[MESH]|Phenylcarbamates/adverse effects/therapeutic use[MESH]|Piperidines/adverse effects/therapeutic use[MESH]|Randomized Controlled Trials as Topic[MESH]|Rivastigmine[MESH]|Tacrine/adverse effects/therapeutic use[MESH] |